4.7 Article

Reversal of Lipid Metabolism Dysregulation by Selenium and Folic Acid Co-Supplementation to Mitigate Pathology in Alzheimer's Disease

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Selenium Restores Synaptic Deficits by Modulating NMDA Receptors and Selenoprotein K in an Alzheimer's Disease Model

Zhong-Hao Zhang et al.

Summary: The study shows that the Se compound Se-Met can restore synaptic deficits in 3 x Tg-AD mice by modulating calcium influx mediated by synaptic and extrasynaptic NMDARs, indicating a potential functional interaction between SELENOK and NMDARs.

ANTIOXIDANTS & REDOX SIGNALING (2021)

Review Medicine, General & Internal

Alzheimer's disease

Philip Scheltens et al.

Summary: Alzheimer's disease is projected to see a significant increase in prevalence in the future, with genetics playing a key role. Novel biomarkers and lifestyle-based prevention trials show promising therapeutic potential. Promising pharmacological treatments are advancing in clinical trials, targeting amyloid beta, tau, and inflammation.

LANCET (2021)

Review Neurosciences

Roles of Selenoproteins in Brain Function and the Potential Mechanism of Selenium in Alzheimer's Disease

Zhong-Hao Zhang et al.

Summary: Selenium and its compounds show potential in preventing and treating Alzheimer's disease, mainly through selenoproteins that play crucial roles in brain function. Analysis of 25 selenoproteins in the brain revealed certain selenoproteins highly expressed in AD-related brain regions, suggesting their involvement in AD pathology. The review discusses the functions of these selenoproteins in AD, indicating new research directions for understanding the mechanism of Selenium in Alzheimer's disease.

FRONTIERS IN NEUROSCIENCE (2021)

Article Clinical Neurology

Alzheimer's disease drug development pipeline: 2021

Jeffrey Cummings et al.

Summary: Overall, the study highlights the urgent need for new treatments for Alzheimer's disease, and shows that a diverse range of drugs targeting the biology of AD are being explored in clinical trials. Biomedical biomarkers are also being increasingly used in these trials to assess effectiveness.

ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS (2021)

Article Clinical Neurology

2021 Alzheimer's disease facts and figures

[Anonymous]

Summary: Alzheimer's disease has a significant impact on individuals and society as a whole, with a large number of patients in the United States and a potential for continued growth in the future. The value of unpaid caregivers has increased despite a decline in their numbers, and healthcare costs are on the rise. Racial and ethnic disparities in healthcare persist, highlighting the need for greater diversity in dementia care workforce and clinical trials.

ALZHEIMERS & DEMENTIA (2021)

Article Clinical Neurology

Failure to demonstrate efficacy of aducanumab: An analysis of the EMERGE and ENGAGE trials as reported by Biogen, December 2019

David S. Knopman et al.

Summary: Aducanumab recently underwent two large phase III clinical trials that were stopped prematurely by the sponsor due to divergent outcomes. One trial showed potential benefits from high doses of Aducanumab, while the other did not show any benefits. Further analysis is needed to determine the true efficacy as a treatment for Alzheimer's disease.

ALZHEIMERS & DEMENTIA (2021)

Article Biochemistry & Molecular Biology

Apolipoprotein E-mediated regulation of selenoprotein P transportation via exosomes

Yunjung Jin et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2020)

Review Biochemistry & Molecular Biology

Lipids and Alzheimer's Disease

Yu-Chia Kao et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Neurosciences

Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer's disease

Tiantian Guo et al.

MOLECULAR NEURODEGENERATION (2020)

Review Pharmacology & Pharmacy

Synaptic dysfunction in Alzheimer's disease: Mechanisms and therapeutic strategies

Yu Chen et al.

PHARMACOLOGY & THERAPEUTICS (2019)

Review Neurosciences

Cell Death Pathways: a Novel Therapeutic Approach for Neuroscientists

G. Morris et al.

MOLECULAR NEUROBIOLOGY (2018)

Review Biochemistry & Molecular Biology

GPx4, Lipid Peroxidation, and Cell Death: Discoveries, Rediscoveries, and Open Issues

Matilde Maiorino et al.

ANTIOXIDANTS & REDOX SIGNALING (2018)

Article Geriatrics & Gerontology

Nutrition and Alzheimer Disease

Shirley Steffany Munoz Fernandez et al.

CLINICS IN GERIATRIC MEDICINE (2018)

Article Biochemistry & Molecular Biology

Folic Acid Reduces Tau Phosphorylation by Regulating PP2A Methylation in Streptozotocin-Induced Diabetic Mice

Miaoyan Zheng et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)

Article Clinical Neurology

Metabolic network failures in Alzheimer's disease: A biochemical road map

Jon B. Toledo et al.

ALZHEIMERS & DEMENTIA (2017)

Article Biochemistry & Molecular Biology

Graded perturbations of metabolism in multiple regions of human brain in Alzheimer's disease: Snapshot of a pervasive metabolic disorder

Jingshu Xu et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2016)

Review Neurosciences

Alzheimer's Disease Risk Genes and Lipid Regulators

Farida El Gaamouch et al.

JOURNAL OF ALZHEIMERS DISEASE (2016)

Article Biochemistry & Molecular Biology

Folic acid administration inhibits amyloid β-peptide accumulation in APP/PS1 transgenic mice

Wen Li et al.

JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2015)

Review Oncology

Regulation of PP2A by sphingolipid metabolism and signaling

Joshua Oaks et al.

FRONTIERS IN ONCOLOGY (2015)

Review Biochemistry & Molecular Biology

Lipoprotein-Associated Oxidative Stress: A New Twist to the Postprandial Hypothesis

Ngoc-Anh Le

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)

Article Food Science & Technology

Effect of methionine-deficient and methionine-supplemented diets on the hepatic one-carbon and lipid metabolism in mice

Alexandre Ferro Aissa et al.

MOLECULAR NUTRITION & FOOD RESEARCH (2014)

Article Clinical Neurology

Amyloid-β and Tau The Trigger and Bullet in Alzheimer Disease Pathogenesis

George S. Bloom

JAMA NEUROLOGY (2014)

Article Biochemistry & Molecular Biology

Analysis of differential plaque depositions in the brains of Tg2576 and Tg-APPswe/PS1dE9 transgenic mouse models of Alzheimer disease

Tae-Kyung Kim et al.

EXPERIMENTAL AND MOLECULAR MEDICINE (2012)

Article Nutrition & Dietetics

Efficacy of Adding Folic Acid to Foods

Violeta Fajardo et al.

INTERNATIONAL JOURNAL FOR VITAMIN AND NUTRITION RESEARCH (2012)

Article Clinical Neurology

Efficacy of a medical food in mild Alzheimer's disease: A randomized, controlled trial

Philip Scheltens et al.

ALZHEIMERS & DEMENTIA (2010)

Review Biochemistry & Molecular Biology

Lipids in Alzheimer's disease: A century-old story

Paul Foley

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2010)

Review Biochemistry & Molecular Biology

Membrane rafts in Alzheimer's disease beta-amyloid production

Kulandaivelu S. Vetrivel et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2010)

Article Geriatrics & Gerontology

Deregulation of sphingolipid metabolism in Alzheimer's disease

Xingxuan He et al.

NEUROBIOLOGY OF AGING (2010)

Article Multidisciplinary Sciences

Treatment of Alzheimer's Disease with Anti-Homocysteic Acid Antibody in 3xTg-AD Male Mice

Tohru Hasegawa et al.

PLOS ONE (2010)

Article Multidisciplinary Sciences

Sodium selenate mitigates tau pathology, neurodegeneration, and functional deficits in Alzheimer's disease models

Janet van Eersel et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)

Review Biochemistry & Molecular Biology

APOE and cholesterol homeostasis in Alzheimer's disease

Valerie Leduc et al.

TRENDS IN MOLECULAR MEDICINE (2010)

Review Biochemistry & Molecular Biology

Homocysteine and lipids: S-Adenosyl methionine as a key intermediate

Rima Obeid et al.

FEBS LETTERS (2009)

Article Medicine, General & Internal

High-dose B vitamin supplementation and cognitive decline in Alzheimer disease - A randomized controlled trial

Paul S. Aisen et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)

Article Medical Laboratory Technology

Hyperhomocysteinemia and high-density lipoprotein metabolism in cardiovascular disease

Dan Liao et al.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2007)

Article Neurosciences

BACE1 interacts with lipid raft proteins.

Chinatsu Hattori et al.

JOURNAL OF NEUROSCIENCE RESEARCH (2006)

Article Biochemistry & Molecular Biology

Inhibition of glycosphingolipid biosynthesis reduces secretion of the β-amyloid precursor protein and amyloid β-peptide

IY Tamboli et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2005)

Article Biochemistry & Molecular Biology

Modulation of amyloid precursor protein cleavage by cellular sphingolipids

N Sawamura et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2004)

Article Neurosciences

Effect of the lipid peroxidation product acrolein on tau phosphorylation in neural cells

A Gómez-Ramos et al.

JOURNAL OF NEUROSCIENCE RESEARCH (2003)

Article Multidisciplinary Sciences

Alzheimer's disease is a synaptic failure

DJ Selkoe

SCIENCE (2002)

Review Medicine, General & Internal

The importance of selenium to human health

MP Rayman

LANCET (2000)